This CDC-funded survey sought to generate a nationally representative estimate of the prevalence of HIV drug resistance (HIVDR) among those initiating ART and the prevalence of viral load suppression and HIVDR at multiple time points after ART initiation in Malawi.
Data Collection Period: 07/2018 – 04/2020